Verena Gotta

777 total citations
56 papers, 548 citations indexed

About

Verena Gotta is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Nephrology. According to data from OpenAlex, Verena Gotta has authored 56 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 10 papers in Molecular Biology and 10 papers in Nephrology. Recurrent topics in Verena Gotta's work include Pharmaceutical studies and practices (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Verena Gotta is often cited by papers focused on Pharmaceutical studies and practices (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Verena Gotta collaborates with scholars based in Switzerland, United States and Netherlands. Verena Gotta's co-authors include Nicolas Widmer, Thierry Buclin, Chantal Csajka, Marc Pfister, Nicole Ritz, Laurent A. Décosterd, Sven Wellmann, Aline Fuchs, Olivera Marsenić and Jeffrey K Aronson and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Verena Gotta

50 papers receiving 543 citations

Peers

Verena Gotta

HEMAT

GENET

PRM

PPCH

Edward C.C. Wong United States

Molla Abebe Ethiopia

John Mondick United States

Jeffrey S. Jhang United States

Christian Laveille France

Karl Brendel France

Massimo Daves Italy

Mona Khurana United States

Søren Blirup-Jensen Sweden

Gabriel Lima-Oliveira Italy

Edward C.C. Wong United States

Verena Gotta

285 ×2.5

HEMAT

141 ×1.5

GENET

144 ×1.7

PRM

83 ×1.0

163 ×2.0

PPCH

Citations per year, relative to Verena Gotta Verena Gotta (= 1×) peers Edward C.C. Wong

Countries citing papers authored by Verena Gotta

Since Specialization

Citations

This map shows the geographic impact of Verena Gotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Gotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Gotta more than expected).

Fields of papers citing papers by Verena Gotta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Gotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Gotta. The network helps show where Verena Gotta may publish in the future.

Co-authorship network of co-authors of Verena Gotta

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Gotta. A scholar is included among the top collaborators of Verena Gotta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Gotta. Verena Gotta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gotta, Verena & Birgit Donner. (2025). QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations. Journal of Pharmacokinetics and Pharmacodynamics. 52(6). 61–61.

Welzel, Tatjana, Andrew Atkinson, Verena Gotta, et al.. (2024). Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases. Pediatric Rheumatology. 22(1). 5–5. 3 indexed citations

Buettcher, Michael, Jörg Huwyler, John van den Anker, et al.. (2024). Pharmacometrics to Evaluate Dosing of the Patient-Friendly Ivermectin CHILD-IVITAB in Children ≥ 15 kg and <15 kg. Pharmaceutics. 16(9). 1186–1186.

Gotta, Verena, et al.. (2024). Antibiotic Exposure of Critically Ill Children at a Tertiary Care Paediatric Intensive Care Unit in Switzerland. Children. 11(6). 731–731.

Rodieux, Frédérique, Victoria C. Ziesenitz, Andrew Atkinson, et al.. (2024). Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study. The Journal of Clinical Pharmacology. 64(7). 810–819. 1 indexed citations

Muff, Roman, et al.. (2024). Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children. Children. 11(11). 1359–1359. 1 indexed citations

Goutelle, Sylvain, Monia Guidi, Verena Gotta, et al.. (2023). From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure. Pharmaceutics. 15(4). 1081–1081. 4 indexed citations

Baumann, Philipp, et al.. (2022). Copeptin Release in Arterial Hypotension and Its Association with Severity of Disease in Critically Ill Children. Children. 9(6). 794–794. 2 indexed citations

Burckhardt, Marie‐Anne, et al.. (2022). Semimechanistic modeling of copeptin and aldosterone kinetics and dynamics in response to rehydration treatment for diabetic ketoacidosis in children. CPT Pharmacometrics & Systems Pharmacology. 12(2). 207–220. 1 indexed citations

10.

Burckhardt, Marie‐Anne, Verena Gotta, Katharina Rentsch, et al.. (2021). Aldosterone and pro-atrial natriuretic peptide kinetics in response to rehydration in children with diabetic ketoacidosis. 94. 1 indexed citations

11.

Koch, Gilbert, Stéphanie Leroux, Verena Gotta, et al.. (2021). Modeling of levothyroxine in newborns and infants with congenital hypothyroidism: challenges and opportunities of a rare disease multi-center study. Journal of Pharmacokinetics and Pharmacodynamics. 48(5). 711–723. 2 indexed citations

12.

Leroux, Stéphanie, Valérie Biran, John van den Anker, et al.. (2021). Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates. Frontiers in Pharmacology. 12. 634686–634686. 5 indexed citations

13.

Gotta, Verena, Olivera Marsenić, Andrew Atkinson, & Marc Pfister. (2021). Hemodialysis (HD) dose and ultrafiltration rate are associated with survival in pediatric and adolescent patients on chronic HD—a large observational study with follow-up to young adult age. Pediatric Nephrology. 36(8). 2421–2432. 3 indexed citations

14.

Allegaert, Karel, Verena Gotta, Anne Smits, et al.. (2020). Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life. Pediatric Nephrology. 36(3). 649–659. 21 indexed citations

15.

Fuchs, Aline, Verena Gotta, Gabor Szinnai, et al.. (2018). Cytokine kinetic profiles in children with acute lower respiratory tract infection: a post hoc descriptive analysis from a randomized control trial. Clinical Microbiology and Infection. 24(12). 1341.e1–1341.e7. 16 indexed citations

16.

Gotta, Verena, et al.. (2017). Cytokine profiling in healthy children shows association of age with cytokine concentrations. Scientific Reports. 7(1). 17842–17842. 57 indexed citations

17.

Winterfeld, Ursula, Verena Gotta, Laura E. Rothuizen, et al.. (2014). Antiepileptika bei Frauen im gebärfähigen Alter und in der Schwangerschaft. Der Nervenarzt. 85(6). 738–746. 1 indexed citations

18.

Gotta, Verena, Nicolas Widmer, Laurent A. Décosterd, et al.. (2014). Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial. Cancer Chemotherapy and Pharmacology. 74(6). 1307–1319. 66 indexed citations

19.

Widmer, Nicolas, Verena Gotta, Amina Haouala, et al.. (2013). Clinical pharmacokinetics of imatinib and its therapeutic relevance. IRIS. 2 indexed citations

20.

Gotta, Verena, Thierry Buclin, Chantal Csajka, & Nicolas Widmer. (2013). Systematic Review of Population Pharmacokinetic Analyses of Imatinib and Relationships With Treatment Outcomes. Therapeutic Drug Monitoring. 35(2). 150–167. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact